AI assistant
Sending…
ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2017
Dec 27, 2017
31071_dirs_2017-12-27_5a86168f-66b8-4325-9a10-fc4d07a7ea43.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK: 0000879407
Period of Report: 2017-12-20
Reporting Person: Waddill William D. (Director)
More from ARROWHEAD PHARMACEUTICALS, INC.
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 7
Report Publication Announcement
2026
May 7
Major Shareholding Notification
2026
May 6
Major Shareholding Notification
2026
Apr 29
Major Shareholding Notification
2026
Apr 28
Major Shareholding Notification
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 20
Interim / Quarterly Report
2026
Feb 5